Triggering uncontrolled cellular proliferation, chronic inflammation, and/or disruption of p53 activity is critical for tumorigenesis initiated by latent viral oncogenes. The adenovirus type 5 (Ad5) early genes E1A and E1B can maintain lifelong latency in the lungs of patients with chronic pulmonary diseases. To determine the in vivo effects of the latent Ad5 E1A and E1B oncogenes, we have examined the influence of Ad5 E1A and E1B gene products on mouse lung carcinogenesis and inflammation by generation and characterization of lungspecific transgenic mouse models. Here, we show that either the Ad5 E1A 243-amino-acid (aa) protein or the E1B 58-kDa protein was dominantly expressed in the transgenic lung. Preferential expression of Ad5 E1A 243-aa protein alone was not sufficient to induce lung carcinogenesis but resulted in low-grade cellular proliferation and high-grade lymphoproliferative inflammation in the lung. The presence of Ad5 E1B dramatically enhanced the expression of the E1A 243-aa protein, in addition to impairing p53 and apoptosis response, resulting in uncontrolled cellular proliferation, lymphoproliferative inflammation, and metastatic carcinomas in the lung after a period of latency. Our studies may provide clues to understanding the potential in vivo biological effects of Ad5 E1A and E1B latent in the lung and a new scope for assessing in vivo functions of viral genes latent in the infection target tissue.Many human viruses such as hepatitis B virus, Epstein-Barr virus, human papillomavirus, Kaposi's sarcoma-associated herpesvirus, and human immunodeficiency virus play a role in oncogenesis by triggering uncontrolled cell proliferation and chronic inflammation and/or disrupting p53 activity in the tissues where the virus causes latent or chronic infection. Human adenovirus type 5 (Ad5) can latently infect human pulmonary tissues. Ad5 early region 1A and 1B (E1A and E1B) genomic DNA can be integrated into the human cell chromosome (12). Either the DNA or the gene products of Ad5 E1A can be frequently detected in the lungs of patients with chronic pulmonary diseases or lung carcinomas (1,7,11,14). However, the role of latent action by the Ad5 E1A and E1B genes in lung carcinogenesis and lymphoproliferative inflammation is unclear.Ad5 E1A and E1B DNA is located within the left-hand 11% of the adenovirus genome. The Ad5 E1A gene encodes two major proteins, the 243-amino-acid (aa) protein and the 289-aa protein, by alternative splicing; likewise, the E1B gene encodes a 58-kDa protein and other, smaller proteins in cell culture (13,17,18,(23)(24)(25). Ad5 E1A is thought to be responsible for the induction of cellular DNA synthesis, inactivation of tumor suppressor pRb, stimulation of cellular transformation, increase in the level of cellular tumor suppressor p53, and cellular apoptosis by means of a series of protein-protein interactions with cellular transcriptional factors, while Ad5 E1B is responsible for the inactivation of tumor suppressor p53 and the repression of cellular apoptosis, leading to pr...